EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Ketamine—From an Anesthetic to a Psychiatric Drug: Mechanisms of Action, Clinical Applications and Potential Risks

Ewa Gibuła-Tarłowska iD, Anna Wiszniewska, Magdalena Turyk, Paulina Szymczyk, Jolanta H Kotlińska iD, Ewa Kędzierska iD

Molecules · 30.06.2025 · 30 (13) · 2824

DOI: 10.3390/molecules30132824 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 30.06.2025. Verfasst von Ewa Gibuła-Tarłowska und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Pharmacodynamics, Faculty of Pharmacy, Medical University of Lublin, 20-093 Lublin, Poland. Hauptthemen laut MEDLINE: Ketamine, Antidepressive Agents, Anesthetics. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 205 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lublin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ketamine, originally developed as an anesthetic, is gaining increasing attention due to its multifaceted pharmacological properties. In addition to its use in anesthesia, ketamine exerts potent analgesic effects via N-methyl-D-aspartate (NMDA) receptor antagonism, modulating pain perception and reducing central sensitization, particularly in chronic and neuropathic pain conditions. Emerging evidence also supports ketamine’s potential in the treatment of substance use disorder, where it may disrupt maladaptive reward-related memories and promote neuroplasticity which facilitates behavioral change. Moreover, in recent years, S-ketamine has shown rapid and potent antidepressant effects, especially in treatment-resistant depression (TRD), probably due to increased glutamatergic signaling, synaptic plasticity and the release of neurotrophic factors. This heterogeneous therapeutic profile positions ketamine as a unique agent at the interface of anesthesia, pain management, addiction medicine and psychiatry, warranting further exploration into its mechanism and long-term effectiveness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KetamineAntidepressive AgentsAnestheticsHumansAnimalsReceptors, N-Methyl-D-AspartateAnalgesicsNeuralgiaSubstance-Related Disorders

Stichwörter der Autor:innen

addictionanesthesiadepressionketaminepain

Substanzen

KetamineAntidepressive AgentsReceptors, N-Methyl-D-AspartateAnalgesicsAnesthetics

Autor:innen und Institutionen

  • Department of Pharmacology and Pharmacodynamics, Faculty of Pharmacy, Medical University of Lublin, 20-093 Lublin, Poland.
  • Student Scientific Club "Synapse", Department of Pharmacology and Pharmacodynamics, Faculty of Pharmacy, Medical University of Lublin, 20-093 Lublin, Poland.

ORCID-Profile: Ewa Gibuła-Tarłowska, Jolanta H Kotlińska, Ewa Kędzierska

Förderung

  • Medical University of Lublin

Zitieren

APA

Gibuła-Tarłowska, E., Wiszniewska, A., Turyk, M., Szymczyk, P., Kotlińska, J. H., & Kędzierska, E. (2025). Ketamine—From an Anesthetic to a Psychiatric Drug: Mechanisms of Action, Clinical Applications and Potential Risks. Molecules, 30(13), 2824. https://doi.org/10.3390/molecules30132824

Vancouver

Gibuła-Tarłowska E, Wiszniewska A, Turyk M, Szymczyk P, Kotlińska JH, Kędzierska E. Ketamine—From an Anesthetic to a Psychiatric Drug: Mechanisms of Action, Clinical Applications and Potential Risks. Molecules. 2025;30(13):2824. doi:10.3390/molecules30132824

BibTeX
@article{GibuaTarowska2025,
  author = {Gibuła-Tarłowska, Ewa and Wiszniewska, Anna and Turyk, Magdalena and Szymczyk, Paulina and Kotlińska, Jolanta H and Kędzierska, Ewa},
  title = {Ketamine—From an Anesthetic to a Psychiatric Drug: Mechanisms of Action, Clinical Applications and Potential Risks},
  journal = {Molecules},
  year = {2025},
  volume = {30},
  number = {13},
  pages = {2824},
  doi = {10.3390/molecules30132824}
}
Kostenlos starten →